Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil

BACKGROUND: Chloroquine (CQ), a cost effective antimalarial drug with a relatively good safety profile and therapeutic index, is no longer used by itself to treat patients with Plasmodium falciparum due to CQ-resistant strains. P. vivax, representing over 90% of malaria cases in Brazil, despite repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguiar, Anna Caroline C, Pereira, Dhelio B, Amaral, Nayra S, De Marco, Luiz, Krettli, Antoniana U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945814/
https://www.ncbi.nlm.nih.gov/pubmed/24581308
http://dx.doi.org/10.1186/1475-2875-13-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945814/
https://www.ncbi.nlm.nih.gov/pubmed/24581308
http://dx.doi.org/10.1186/1475-2875-13-73

Ejemplares similares